eIF4GI, for instance, is overexpressed in breast and lung cancers and enhances the translation of mRNAs that are involved in survival (Hif-1a, VEGF), cell signaling (cadherins), and DNA damage repair (p53, p53-BP1, and PARP) [1–6]. This evidence concerns the gene TP53 and lung cancer.